Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-17

FDA Approved: FLUVOXAMINE MALEATE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original ANDA for fluvoxamine maleate, providing a generic version of the antidepressant used to treat obsessive-compulsiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luvox (Fluvoxamine maleate) (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)